We are live on ! Find out more
GA

Geneva Advisors Portfolio holdings

AUM $5.81B Turnover 22.5%
1-Year Est. Return 23.71%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.37B
AUM Growth
+$62.8M
Cap. Flow
-$112M
Cap. Flow %
-2.09%
Top 10 Hldgs %
20.35%
Holding
855
New
121
Increased
189
Reduced
310
Closed
120
Avg Time Held
1 year
Top 10 Avg Time Held
0.6 years
Top 20 Avg Time Held
0.6 years

Top Buys

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$45.7M
2
IDXX icon
Idexx Laboratories
IDXX
+$34.3M
3
CAH icon
Cardinal Health
CAH
+$30.2M
4
AMAT icon
Applied Materials
AMAT
+$24.5M
5
ELV icon
Elevance Health
ELV
+$24.1M

Sector Composition

Rank Sector Weight
1 Healthcare 18.73%
2 Financials 15.53%
3 Industrials 13.23%
4 Consumer Discretionary 12.83%
5 Technology 10.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
SBY
251
DELISTED
Silver Bay Realty Trust Corp.
SBY
$1.19M 0.02%
71,616
– –
2013 Q2
6 quarters
KYN icon
252
Kayne Anderson Energy Infrastructure Fund
KYN
$2.36B
$1.18M 0.02%
30,889
+395
+1% +$15.3K
2013 Q2
6 quarters
NXPI icon
253
NXP Semiconductors
NXPI
$58.3B
$1.17M 0.02%
+15,342
New +$1.09M
2014 Q4
0 quarters
PHO icon
254
Invesco Water Resources ETF
PHO
$1.95B
$1.16M 0.02%
45,035
-3,720
-8% -$94.3K
2013 Q2
6 quarters
JEF icon
255
Jefferies Financial Group
JEF
$10.3B
$1.15M 0.02%
57,245
-4,322
-7% -$89.2K
2013 Q2
6 quarters
IEV icon
256
iShares Europe ETF
IEV
$1.6B
$1.12M 0.02%
26,395
+1,490
+6% +$64.9K
2014 Q1
3 quarters
VNRBP
257
DELISTED
Vanguard Natural Resources LLC 7.625% Series B Cumulative Redeemable Perpetual Preferred Unit
VNRBP
$1.11M 0.02%
57,450
-5,800
-9% -$125K
2014 Q1
3 quarters
XLF icon
258
State Street Financial Select Sector SPDR ETF
XLF
$51.4B
$1.11M 0.02%
51,053
-1,082
-2% -$22.7K
2013 Q4
4 quarters
MHNB.CL
259
DELISTED
Maiden Holdings North America
MHNB.CL
$1.08M 0.02%
40,800
+2,000
+5% +$52.9K
2013 Q2
6 quarters
WY icon
260
Weyerhaeuser
WY
$14B
$1.08M 0.02%
30,116
-892
-3% -$30.6K
2014 Q1
3 quarters
ADP icon
261
Automatic Data Processing
ADP
$113B
$1.08M 0.02%
12,928
-3,348
-21% -$271K
2013 Q2
6 quarters
HOLX icon
262
DELISTED
Hologic
HOLX
$1.06M 0.02%
39,813
-1,517
-4% -$39.2K
2014 Q1
3 quarters
INGR icon
263
Ingredion
INGR
$6.13B
$1.06M 0.02%
12,445
-240
-2% -$19.1K
2014 Q1
3 quarters
IVR.PRB icon
264
DELISTED
INVESCO MORTGAGE CAPITAL INC. 7.75% Fixed-To-Floating Series B Cumulative Redeemable Preferred Stock
IVR.PRB
$1.05M 0.02%
46,300
+1,900
+4% +$45.5K
2014 Q3
1 quarter
DTV
265
DELISTED
DIRECTV COM STK (DE)
DTV
$1.05M 0.02%
12,128
+19
+0.2% +$1.64K
2013 Q2
6 quarters
AX icon
266
Axos Financial
AX
$4.97B
$1.05M 0.02%
+54,000
New +$1.01M
2014 Q4
0 quarters
OXSQ icon
267
Oxford Square Capital
OXSQ
$151M
$1.05M 0.02%
138,998
+1,800
+1% +$15.1K
2013 Q3
5 quarters
LEG icon
268
DELISTED
Leggett & Platt
LEG
$1.04M 0.02%
24,504
+18,532
+310% +$730K
2014 Q2
2 quarters
EOG icon
269
EOG Resources
EOG
$80.1B
$1.04M 0.02%
11,288
-5,013
-31% -$467K
2013 Q2
6 quarters
FULLL
270
DELISTED
Great Elm Capital Corp. 8.25% Notes due 2020
FULLL
$1.04M 0.02%
40,200
+5,400
+16% +$141K
2013 Q2
6 quarters
JCI icon
271
Johnson Controls International
JCI
$89.4B
$1.03M 0.02%
20,353
-933
-4% -$45.6K
2014 Q1
3 quarters
CF icon
272
CF Industries
CF
$18.1B
$1.03M 0.02%
18,840
-250
-1% -$13.2K
2013 Q2
6 quarters
EW icon
273
Edwards Lifesciences
EW
$50.8B
$1.02M 0.02%
48,282
-1,026
-2% -$20.6K
2013 Q2
6 quarters
SHLX
274
DELISTED
Shell Midstream Partners, L.P.
SHLX
$1.02M 0.02%
+25,000
New +$887K
2014 Q4
0 quarters
RH icon
275
RH
RH
$2.23B
$1.02M 0.02%
+10,635
New +$891K
2014 Q4
0 quarters

Similar funds

Geneva Advisors's Q4 2014 Portfolio in Review

As of Q4 2014, Geneva Advisors held 855 positions worth $5.37B, up 1.2% from $5.31B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Geneva Advisors's Q4 2014 filing shows 121 new, 189 increased, 310 reduced and 120 closed positions. Its largest new stake was Idexx Laboratories: 488,650 shares worth $36.2M. The largest sale was LyondellBasell Industries, an estimated $73.1M.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Geneva Advisors's largest Q4 2014 buy was Idexx Laboratories: 488,650 shares worth $36.2M.
  • Geneva Advisors added most to Alibaba in Q4 2014, an estimated $45.7M increase.
  • Geneva Advisors's biggest Q4 2014 reduction was LyondellBasell Industries, cutting an estimated $73.1M.
  • Geneva Advisors fully exited Community Health Systems in Q4 2014, selling an estimated $13M.
  • Geneva Advisors's ten largest holdings make up 20% of its $5.37B portfolio in Q4 2014.
  • Geneva Advisors opened 121 new positions and closed 120 in Q4 2014.
  • Geneva Advisors's portfolio value rose 1.2% quarter-over-quarter to $5.37B.

Based on Geneva Advisors's 13F filing for Q4 2014, filed 2 Feb 2015.